As of 2024-07-27, the EV/EBITDA ratio of Paratek Pharmaceuticals Inc (PRTK) is -7.74. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRTK's latest enterprise value is 343.47 mil USD. PRTK's TTM EBITDA according to its financial statements is -44.39 mil USD. Dividing these 2 quantities gives us the above PRTK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 15.9x | 13.3x |
| Forward P/E multiples | 13.9x - 20.2x | 16.6x |
| Fair Price | (14.49) - (16.07) | (15.36) |
| Upside | -750.0% - -820.8% | -788.7% |
| Date | EV/EBITDA |